191 related articles for article (PubMed ID: 35018247)
21. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
22. Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
Kamiya H; Komatsu S; Takashima Y; Ishida R; Arakawa H; Nishibeppu K; Kiuchi J; Imamura T; Ohashi T; Shimizu H; Arita T; Konishi H; Shiozaki A; Kubota T; Fujiwara H; Yagyu S; Iehara T; Otsuji E
Br J Cancer; 2024 Mar; 130(4):671-681. PubMed ID: 38148376
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
24. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
[TBL] [Abstract][Full Text] [Related]
25. [Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism].
Qiu G; Wang S; Li D; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):1036-9. PubMed ID: 25341915
[TBL] [Abstract][Full Text] [Related]
26. The role of miR-148a in gastric cancer.
Xia J; Guo X; Yan J; Deng K
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1451-6. PubMed ID: 24659367
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
[TBL] [Abstract][Full Text] [Related]
28. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.
Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R
Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.
Zhang BX; Yu T; Yu Z; Yang XG
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6497-6504. PubMed ID: 31378889
[TBL] [Abstract][Full Text] [Related]
30. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
31. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
33. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
Ma L; Xu Z; Xu C; Jiang X
Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.
Liu J; Si L; Tian H
Exp Ther Med; 2018 Dec; 16(6):5400-5409. PubMed ID: 30546419
[TBL] [Abstract][Full Text] [Related]
36. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
37. MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.
Zhang L; Xing M; Wang X; Cao W; Wang H
Int J Clin Exp Pathol; 2017; 10(8):8361-8368. PubMed ID: 31966687
[TBL] [Abstract][Full Text] [Related]
38. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.
Xu TJ; Qiu P; Zhang YB; Yu SY; Xu GM; Yang W
Hum Cell; 2019 Oct; 32(4):548-556. PubMed ID: 31489579
[TBL] [Abstract][Full Text] [Related]
39. CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.
Sun J; Yin A; Zhang W; Lv J; Liang Y; Li H; Li Y; Li X
Cell Transplant; 2020; 29():963689720925751. PubMed ID: 32425115
[TBL] [Abstract][Full Text] [Related]
40. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.
Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG
Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
